Abstract:A genetic bottleneck is a hallmark of HIV-1 transmission such that only very few viral strains, termed transmitted/founder (T/F) variants establish infection in a newly infected host. Phenotypic characteristics of these variants may determine the subsequent course of disease. The HIV-1 5' long terminal repeat (LTR) promoter drives viral gene transcription and is genetically identical to the 3' LTR. We hypothesized that HIV-1 subtype C (HIV-1C) T/F virus LTR genetic variation is a determinant of transcriptional activation potential and clinical disease outcome. The 3'LTR was amplified from plasma samples of 41 study participants acutely infected with HIV-1C (Fiebig stages I and V/VI). Paired longitudinal samples were also available at one year post-infection for 31 of the 41 participants. 3' LTR amplicons were cloned into a pGL3-basic luciferase expression vector, and transfected alone or together with Transactivator of transcription (tat) into Jurkat cells in the absence or presence of cell activators (TNF-α, PMA, Prostratin and SAHA). Inter-patient T/F LTR sequence diversity was 5.7% (Renge: 2-12) with subsequent intrahost viral evolution observed in 48.4% of the participants analyzed at 12 months post-infection. T/F LTR variants exhibited differential basal transcriptional activity, with significantly higher Tat-mediated transcriptional activity compared to basal (p<0.001). Basal and Tat-mediated T/F LTR transcriptional activity showed significant positive correlation with contemporaneous viral loads and negative correlation with CD4 T cell counts (p<0.05) during acute infection respectively. Furthermore, Tat-mediated T/F LTR transcriptional activity significanly correlated positively with viral load set point and viral load; and negatively with CD4 T cell counts at one year post infection (all p<0.05). Lastly, PMA, Prostratin, TNF-α and SAHA cell stimulation resulted in enhanced yet heterologous transcriptional activation of different T/F LTR variants. Our data suggest that T/F LTR variants may influence viral transcriptional activity, disease outcomes and sensitivity to cell activation, with potential implications for therapeutic interventions.

Transcriptome Analysis of CD4 T Cells from HIV-infected Individuals Receiving ART with LLV Revealed Novel Transcription Factors Regulating HIV-1 Promoter Activity

Identification of CD98 As a Novel Biomarker for HIV-1 Permissiveness and Latent Infection

Altered differentiation is central to HIV-specific CD4+ T cell dysfunction in progressive disease

Seeking "protective" and "harmful" immune genes during chronic HIV-1 infection by transcriptome analysis

An Integrative Genomic Analysis of Transcriptional Profiles Identifies Characteristic Genes and Patterns in HIV-infected Long-Term Non-Progressors and Elite Controllers

The Expression And Clinical Significance Of Foxp3 Mrna In Peripheral Blood Monocytes From Hiv/Aids Patients

Genome-wide analysis of primary CD4+ and CD8+ T cell transcriptomes shows evidence for a network of enriched pathways associated with HIV disease

Global transcriptomic characterization of T cells in individuals with chronic HIV-1 infection

Increased Expression of BCL11B and Its Recruited Chromatin Remodeling Factors During Highly Active Antiretroviral Therapy Synergistically Represses the Transcription of Human Immunodeficiency Virus Type 1 and is Associated with Residual Immune Activation

Altered T-Cell Subsets Are Associated with Dysregulated Cytokine Secretion of CD4+ T Cells During HIV Infection

CCL5-Secreting Virtual Memory CD8+ T Cells Inversely Associate With Viral Reservoir Size in HIV‐1−Infected Individuals on Antiretroviral Therapy

Differential Expression of Innate Immunity Regulation Genes in Chronic HIV-1 Infected Adults.

Transcriptomic Study Reveals Changes of Lncrnas in PBMCs from HIV-1 Patients Before and after ART

Transcriptional Profiling of CD4 T Cells Identifies Distinct Subgroups of HIV-1 Elite Controllers

CD4 T-cell transcriptome expression reversal of the lncRNA-mRNA co-expression network in elite controller vs. normal-process HIV patients

RNA Sequencing of CD4 T-cells Reveals the Relationships Between Lncrna-Mrna Co-Expression in Elite Controller Vs. HIV-positive Infected Patients.

Parallel analysis of transcription, integration, and sequence of single HIV-1 proviruses

Landscape of T Cells Transcriptional and Metabolic Modules During HIV Infection Based on Weighted Gene Co-expression Network Analysis

Cognate Antigen Engagement Induces HIV-1 Expression In CD4 T Cells From People On Long-Term ART

Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes

Single-cell transcriptional landscapes reveal HIV-1-driven aberrant host gene transcription as a potential therapeutic target